Physician

Alyson W Smith, MD

According to 2025 Medicare claims, Alyson Smith, MD (NPI: 1639107980) practices allergy/immunology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is SBH PHYSICIANS, PC (NPI: 1457665937; TIN: 272892195) and primary practice location at 10457-2545.

Smith's data goes back to 2015 and runs through 2024. For example, in 2018, this provider had 13 traditional Medicare patients, billed 32 HCPCS/CPT codes, and received $1,312 in Medicare payments. 2024 Part D data shows 342 prescription claims across 41 beneficiaries totaling $184,369 in drug costs, led by Xolair (Omalizumab). 2023 DME data shows 11 claims. Open Payments data shows 42 records totaling $836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $39,055 and ending at $184,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$656$1.3K2018 Medicare payment: $1,312 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181332$1,312
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$92K$184K2015 Drug cost: $39,055 (USD; Tot_Drug_Cst)2016 Drug cost: $12,614 (USD; Tot_Drug_Cst)2017 Drug cost: $10,159 (USD; Tot_Drug_Cst)2018 Drug cost: $17,574 (USD; Tot_Drug_Cst)2019 Drug cost: $24,691 (USD; Tot_Drug_Cst)2020 Drug cost: $38,903 (USD; Tot_Drug_Cst)2021 Drug cost: $24,911 (USD; Tot_Drug_Cst)2022 Drug cost: $6,679 (USD; Tot_Drug_Cst)2023 Drug cost: $33,443 (USD; Tot_Drug_Cst)2024 Drug cost: $184,369 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201525133$39,055
201625106$12,614
201732145$10,159
201838167$17,574
201945247$24,691
202040284$38,903
202135189$24,911
202229109$6,679
202341206$33,443
202441342$184,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$390$7792023 Medicare payment: $779 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R11$779
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab732,044$127,195
EpinephrineEpinephrine18540$5,350
SymbicortBudesonide/Formoterol Fumarate23690$4,882
Albuterol Sulfate HfaAlbuterol Sulfate23582$734
Azelastine HclAzelastine Hcl29870$623

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$836AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alyson W. Smith, MD?

Tedicare shows public-source Medicare data for Alyson W. Smith, MD (NPI 1639107980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alyson W. Smith, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alyson W. Smith, MD?

Alyson W. Smith, MD is linked to SBH PHYSICIANS, PC (billing NPI 1457665937) in the available physician profile data.

Does Alyson W. Smith, MD have Open Payments data?

Alyson W. Smith, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.